Onno Kranenburg

Now

Trials, publications and grants since Nov 2024.

• Publication

  DuoBody®-FAPαxDR4 is a novel DR4 agonist that induces potent antitumor activity through FAPα-dependent, DR4-transactivation-mediated apoptosis.

  Clinical cancer research : an official journal of the American Association for Cancer Research, Oct 2026

• Publication

  Survival impact of involvement of lymph node stations 16b1, 9, and 8a during pancreatoduodenectomy for pancreatic and periampullary cancers (PANODE): prospective multicentre study.

  BJS open, Sept 2026

• Publication

  ATR inhibitors synergise with mitomycin C to enhance cytotoxicity in patient-derived non-muscle invasive bladder cancer organoids.

  British journal of cancer, Aug 2026

• Publication

  Surgical outcomes from nationwide implementation of the international best practice for locally advanced pancreatic cancer (PREOPANC-4) study.

  The British journal of surgery, Aug 2026

• Publication

  Site-dependent Treg cell transcriptional reprogramming in a metastatic colorectal cancer model holds prognostic significance.

  Cancer letters, Jun 2026

• Publication

  Continuity of care experienced by patients diagnosed with pancreatic cancer: nationwide multicentre study.

  BJS open, May 2026

• Publication

  Emergence of oncofetal plasticity is ubiquitous in early colorectal cancers.

  Nature, Apr 2026

• Publication

  Targeting the DNA damage response prevents regrowth of colorectal peritoneal metastasis-derived organoids following treatment with mitomycin C.

  British journal of cancer, Jan 2026

• Publication

  Clinical implications of whole genome sequencing in metastatic colorectal cancer.

  Oncogene, Nov 2025

• Publication

  Impact of treatment history on drug resistance of metastatic colorectal cancer organoids.

  iScience, Oct 2025

Affiliations

• University Medical Center Utrecht
• Utrecht University

Co-authors

• BKBas Groot KoerkampHow are we linked?

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.